Open | - |
Close | - |
Volume / Avg. | 0 / 164.794K |
Day Range | - - - |
52 Wk Range | 0.338 - 1.650 |
Market Cap | $17.776M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 0.43% |
Days to Cover | 1.67 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Moleculin Biotech (NASDAQ: MBRX) through any online brokerage.
Other companies in Moleculin Biotech’s space includes: Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), T2 Biosystems (NASDAQ:TTOO), Lumos Pharma (NASDAQ:LUMO) and Evaxion Biotech (NASDAQ:EVAX).
The latest price target for Moleculin Biotech (NASDAQ: MBRX) was reported by HC Wainwright & Co. on Thursday, December 14, 2023. The analyst firm set a price target for 3.00 expecting MBRX to rise to within 12 months (a possible 463.91% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Moleculin Biotech (NASDAQ: MBRX) is $0.532 last updated March 18, 2024 at 7:24 PM EDT.
There are no upcoming dividends for Moleculin Biotech.
Moleculin Biotech’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Moleculin Biotech.
Moleculin Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.